Literature DB >> 963010

Nearest neighbor analysis of heparin: identification and quantitation of the products formed by selective depolymerization procedures.

J E Shively, H E Conrad.   

Abstract

Heparin was carboxyl-reduced with sodium boro[3H]hydride and converted to a mixture of oligosaccharides by treatment with nitrous acid at pH 2. The oligosaccharide mixture was aldehyde-reduced with sodium boro[3H]hydride and the mixture of products, labeled both in the hexoses formed in the carboxyl-reduction step and in the reducing sugars formed in the nitrous acid reaction, was separated and analyzed. The major product, L-idosyl 2-sulfate leads to anhydro-D-mannitol 6-sulfate (I), contained 60% of hexoses derived from the hexuronic acid residues in the original heparin. A second product, which contained 15% of the hexoses derived from the hexuronic acid residues in the original heparin, was identified as a tetrasaccharide composed of two L-idosyl 2-sulfate residues, one anhydro-D-mannitol 6-sulfate residue (the reducing end),and a hydroxymethylpentose sulfate residue formed by deamination of a disulfated D-glucosamine residue without bond cleavage. Several additional disaccharides derived from the regions of the polymer which contained D-glucuronic acid residues and lower degrees of O-sulfation were also identified among the deamination products. The oligosaccharides that were obtained accounted for 100% of the original carboxyl-reduced heparin, and paper chromatographic profiles of the oligosaccharide separations can be used as a fingerprint of the heparin preparation. The properties of I were examined in greater detail. The glycosidic bond of the L-idosyl 2-sulfate residue was found to be extremely labile to 0.1 N HCl at 100 degrees C, hydrolyzing with a t 1/2 of 18 min to give high yields of L-idose 2-sulfate and anhydro-D-mannitol 6-sulfate. L-Idofuranose was also identified as an intermediate in the conversion of L-idose 2-sulfate to L-idosan. The acid lability of the L-idosyl 2-sulfate bond in I offers a new route for the selective cleavage of carboxyl-reduced heparin.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 963010     DOI: 10.1021/bi00663a006

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  32 in total

1.  Binding of perlecan to transthyretin in vitro.

Authors:  S Smeland; S O Kolset; M Lyon; K R Norum; R Blomhoff
Journal:  Biochem J       Date:  1997-09-15       Impact factor: 3.857

2.  Nitric oxide degradation of heparin and heparan sulphate.

Authors:  R E Vilar; D Ghael; M Li; D D Bhagat; L M Arrigo; M K Cowman; H S Dweck; L Rosenfeld
Journal:  Biochem J       Date:  1997-06-01       Impact factor: 3.857

Review 3.  Structure and function of heparan sulphate proteoglycans.

Authors:  J T Gallagher; M Lyon; W P Steward
Journal:  Biochem J       Date:  1986-06-01       Impact factor: 3.857

4.  Drosophila syndecan: conservation of a cell-surface heparan sulfate proteoglycan.

Authors:  J Spring; S E Paine-Saunders; R O Hynes; M Bernfield
Journal:  Proc Natl Acad Sci U S A       Date:  1994-04-12       Impact factor: 11.205

5.  Hydrazinolysis of heparin and other glycosaminoglycans.

Authors:  P N Shaklee; H E Conrad
Journal:  Biochem J       Date:  1984-01-01       Impact factor: 3.857

6.  The disaccharides formed by deaminative cleavage of N-deacetylated glycosaminoglycans.

Authors:  P N Shaklee; H E Conrad
Journal:  Biochem J       Date:  1986-04-01       Impact factor: 3.857

7.  Structural studies on heparan sulphate from human lung fibroblasts. Characterization of oligosaccharides obtained by selective periodate oxidation of D-glucuronic acid residues followed by scission in alkali.

Authors:  I Sjöberg; L A Fransson
Journal:  Biochem J       Date:  1980-10-01       Impact factor: 3.857

8.  Defective N-sulfation of heparan sulfate proteoglycans limits PDGF-BB binding and pericyte recruitment in vascular development.

Authors:  Alexandra Abramsson; Sindhulakshmi Kurup; Marta Busse; Shuhei Yamada; Per Lindblom; Edith Schallmeiner; Denise Stenzel; Dominique Sauvaget; Johan Ledin; Maria Ringvall; Ulf Landegren; Lena Kjellén; Göran Bondjers; Jin-ping Li; Ulf Lindahl; Dorothe Spillmann; Christer Betsholtz; Holger Gerhardt
Journal:  Genes Dev       Date:  2007-02-01       Impact factor: 11.361

9.  Biosynthesis of heparin. Use of Escherichia coli K5 capsular polysaccharide as a model substrate in enzymic polymer-modification reactions.

Authors:  M Kusche; H H Hannesson; U Lindahl
Journal:  Biochem J       Date:  1991-04-01       Impact factor: 3.857

10.  Evaluation of critical groups required for the binding of heparin to antithrombin.

Authors:  D H Atha; A W Stephens; R D Rosenberg
Journal:  Proc Natl Acad Sci U S A       Date:  1984-02       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.